The innate immune response to pneumococcal lung infection: the untold story.
about
Modulation of the lung inflammatory response to serotype 8 pneumococcal infection by a human immunoglobulin m monoclonal antibody to serotype 8 capsular polysaccharide.Efficacy profiles of daptomycin for treatment of invasive and noninvasive pulmonary infections with Streptococcus pneumoniaeInfection of zebrafish embryos with live fluorescent Streptococcus pneumoniae as a real-time pneumococcal meningitis model.T regulatory cells control susceptibility to invasive pneumococcal pneumonia in miceBlood Group Antigen Recognition by a Solute-Binding Protein from a Serotype 3 Strain of Streptococcus pneumoniaeDifferential Recognition and Hydrolysis of Host Carbohydrate Antigens by Streptococcus pneumoniae Family 98 Glycoside HydrolasesThe molecular basis of glycogen breakdown and transport in Streptococcus pneumoniaeStructural insights into catalytic and substrate binding mechanisms of the strategic EndA nuclease from Streptococcus pneumoniaeInsights into the interaction between influenza virus and pneumococcusBlood group antigen recognition by a Streptococcus pneumoniae virulence factor.Increased susceptibility for superinfection with Streptococcus pneumoniae during influenza virus infection is not caused by TLR7-mediated lymphopenia.Radiographic features of Mycoplasma pneumoniae pneumonia: differential diagnosis and performance timing.Characterization of novel beta-galactosidase activity that contributes to glycoprotein degradation and virulence in Streptococcus pneumoniae.E-prostanoid 3 receptor deletion improves pulmonary host defense and protects mice from death in severe Streptococcus pneumoniae infectionCigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae.Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivoThe RNA uridyltransferase Zcchc6 is expressed in macrophages and impacts innate immune responses.The natural cytotoxicity receptor 1 contribution to early clearance of Streptococcus pneumoniae and to natural killer-macrophage cross talk.The impact of pneumolysin on the macrophage response to Streptococcus pneumoniae is strain-dependent.Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage.The efficacy of pneumococcal capsular polysaccharide-specific antibodies to serotype 3 Streptococcus pneumoniae requires macrophages.Passive immunization with Pneumovax® 23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis.Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary diseaseMathematical model of a three-stage innate immune response to a pneumococcal lung infectionCloning, recombinant production, crystallization and preliminary X-ray diffraction analysis of a family 101 glycoside hydrolase from Streptococcus pneumoniaeAnimals devoid of pulmonary system as infection models in the study of lung bacterial pathogensHuman L-ficolin, a recognition molecule of the lectin activation pathway of complement, activates complement by binding to pneumolysin, the major toxin of Streptococcus pneumoniae.Protection against lethal challenge with Streptococcus pneumoniae is conferred by aryl hydrocarbon receptor activation but is not associated with an enhanced inflammatory responseGenetic factors regulating lung vasculature and immune cell functions associate with resistance to pneumococcal infectionDifference in Resistance to Streptococcus pneumoniae Infection in MiceEnhanced inflammation in aged mice following infection with Streptococcus pneumoniae is associated with decreased IL-10 and augmented chemokine production.Type 1 interferon gene transfer enhances host defense against pulmonary Streptococcus pneumoniae infection via activating innate leukocytesThe polysaccharide capsule of Streptococcus pneumonia partially impedes MyD88-mediated immunity during pneumonia in micePneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice.Tumor necrosis factor-alpha deficiency impairs host defense against Streptococcus pneumoniaeRole of Nucleotide-Binding Oligomerization Domain-Containing (NOD) 2 in Host Defense during Pneumococcal Pneumonia.Pneumococcal vaccine development.E-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumoniae.Mechanistic exploration of AhR-mediated host protection against Streptococcus pneumoniae infection.Bacterial exploitation of phosphorylcholine mimicry suppresses inflammation to promote airway infection.
P2860
Q24532019-D0194130-B05D-4563-B349-3EEC65C69346Q24656785-E719F955-3223-43B7-96A5-02696943DC25Q27303066-5349A5C9-D0D8-414F-9434-81CE87EA55FEQ27346256-D1D15FDC-56D1-478F-AFE4-FFA10C7319E9Q27654107-089FEAC9-0B53-4A67-A9AD-CCDF6A9927B2Q27656489-43F893BD-6769-47EF-9145-6A9509B40ECFQ27661881-B71D7724-0991-406F-8D40-CD2D362A7E4CQ27666089-292C5AE5-C7D3-4B46-852A-66BCCFA27855Q30355570-E669D304-C427-4821-AE8D-5EC4D6F0897DQ31061712-CBA2E7FB-217E-4B6E-8BD2-568298352964Q33418589-AF12FF60-F5CC-4B6B-AEDE-29ED1B18593DQ33436088-82FD9C47-187B-4E67-B2AB-88072DBCB2E5Q33557890-63EB91E8-0C87-4332-87C4-140D02525FBCQ33594642-A01B8682-197D-48C4-A423-C9E7502E8F9AQ33675787-3E00B112-684F-4DAA-AE80-930F2A94D30BQ33825652-2342CCE5-366A-4563-BB51-0A890BDCE9B3Q33859901-FC1CDDB7-78EB-4A9C-B5F8-0FC0FCE64E5CQ34009337-C95922E0-26E9-4C8F-9A2F-88AAB7762AF0Q34020348-8CE0F9D1-02BA-477B-B87B-66AEE7CFEBDCQ34229627-FD4B283D-1223-4646-888D-DE313EC7693AQ34238386-95B0FCC8-73D7-4EB6-A5BD-36E02870BD73Q34621983-4F985069-7340-40BF-9D9D-FECE41DA1DCFQ34721302-0C5252CA-8304-40C4-8011-5274E9E03154Q34733562-3F7A4003-9FBE-4E6A-8ECE-5B80E07B0535Q34937568-07B3131C-AFEA-4245-9988-FF5D05455067Q35048029-2705C046-AEE4-40EC-B364-C77AA1E20A67Q35070388-8A48D326-E57A-4853-ACD7-D213CD778A1EQ35073987-7224FF6D-B717-4F62-855B-78C9DAD6EA3BQ35110974-0C0A2F87-80DE-4104-8D05-E32B5D7FDF24Q35134987-139C68FB-509E-4D6E-BEA1-4C6628CABCD9Q35178687-66AD36FE-BB3F-4B67-B608-17C752AE8AAFQ35229035-47B84BA6-3077-4962-BBD8-C83079696E6CQ35564597-2F52EF2C-9D40-4A29-9C79-18A012F617DFQ35783722-1BC77161-F198-436B-9185-67E402A13944Q35812602-505F6553-ED96-4389-BCF0-FE23B322FA26Q35870208-BF43D380-A3E1-4F4E-A522-6947855DEBACQ35918513-BFE71056-2D32-4B6B-83B5-83AA26DFA7A3Q35954130-5DCEB688-84A4-43C8-AF96-164388FB8400Q36074679-0985F786-DE74-45F1-B8C5-68E9A8281EB9Q36165636-B0D13E02-8F20-454F-B89C-252E40DE8AAF
P2860
The innate immune response to pneumococcal lung infection: the untold story.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The innate immune response to pneumococcal lung infection: the untold story.
@ast
The innate immune response to pneumococcal lung infection: the untold story.
@en
type
label
The innate immune response to pneumococcal lung infection: the untold story.
@ast
The innate immune response to pneumococcal lung infection: the untold story.
@en
prefLabel
The innate immune response to pneumococcal lung infection: the untold story.
@ast
The innate immune response to pneumococcal lung infection: the untold story.
@en
P356
P1433
P1476
The innate immune response to pneumococcal lung infection: the untold story
@en
P2093
Peter W Andrew
P304
P356
10.1016/J.IT.2003.12.006
P577
2004-03-01T00:00:00Z